362 related articles for article (PubMed ID: 27215931)
1. Accelerated Brain DCE-MRI Using Iterative Reconstruction With Total Generalized Variation Penalty for Quantitative Pharmacokinetic Analysis: A Feasibility Study.
Wang C; Yin FF; Kirkpatrick JP; Chang Z
Technol Cancer Res Treat; 2017 Aug; 16(4):446-460. PubMed ID: 27215931
[TBL] [Abstract][Full Text] [Related]
2. Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
Xie T; Chen X; Fang J; Kang H; Xue W; Tong H; Cao P; Wang S; Yang Y; Zhang W
J Magn Reson Imaging; 2018 Apr; 47(4):1099-1111. PubMed ID: 28845594
[TBL] [Abstract][Full Text] [Related]
3. Direct parametric reconstruction from undersampled (k, t)-space data in dynamic contrast enhanced MRI.
Dikaios N; Arridge S; Hamy V; Punwani S; Atkinson D
Med Image Anal; 2014 Oct; 18(7):989-1001. PubMed ID: 24972377
[TBL] [Abstract][Full Text] [Related]
4. Intra-individual comparison of different gadolinium-based contrast agents in the quantitative evaluation of C6 glioma with dynamic contrast-enhanced magnetic resonance imaging.
Li Y; Liu G; Lou X; Chen Z; Ma L
Sci China Life Sci; 2017 Jan; 60(1):11-15. PubMed ID: 28078511
[TBL] [Abstract][Full Text] [Related]
5. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
[TBL] [Abstract][Full Text] [Related]
6. Direct estimation of tracer-kinetic parameter maps from highly undersampled brain dynamic contrast enhanced MRI.
Guo Y; Lingala SG; Zhu Y; Lebel RM; Nayak KS
Magn Reson Med; 2017 Oct; 78(4):1566-1578. PubMed ID: 27859563
[TBL] [Abstract][Full Text] [Related]
7. Assessment of DCE-MRI parameters for brain tumors through implementation of physiologically-based pharmacokinetic model approaches for Gd-DOTA.
Spanakis M; Kontopodis E; Van Cauter S; Sakkalis V; Marias K
J Pharmacokinet Pharmacodyn; 2016 Oct; 43(5):529-47. PubMed ID: 27647272
[TBL] [Abstract][Full Text] [Related]
8. Pseudo Test-Retest Evaluation of Millimeter-Resolution Whole-Brain Dynamic Contrast-enhanced MRI in Patients with High-Grade Glioma.
Bliesener Y; Lebel RM; Acharya J; Frayne R; Nayak KS
Radiology; 2021 Aug; 300(2):410-420. PubMed ID: 34100683
[TBL] [Abstract][Full Text] [Related]
9. Joint arterial input function and tracer kinetic parameter estimation from undersampled dynamic contrast-enhanced MRI using a model consistency constraint.
Guo Y; Lingala SG; Bliesener Y; Lebel RM; Zhu Y; Nayak KS
Magn Reson Med; 2018 May; 79(5):2804-2815. PubMed ID: 28905411
[TBL] [Abstract][Full Text] [Related]
10. Dynamic contrast-enhanced MRI parametric mapping using high spatiotemporal resolution Golden-angle RAdial Sparse Parallel MRI and iterative joint estimation of the arterial input function and pharmacokinetic parameters.
Mazaheri Y; Kim N; Lakhman Y; Jafari R; Vargas A; Otazo R
NMR Biomed; 2022 Jul; 35(7):e4718. PubMed ID: 35226774
[TBL] [Abstract][Full Text] [Related]
11. Tracer kinetic models as temporal constraints during brain tumor DCE-MRI reconstruction.
Lingala SG; Guo Y; Bliesener Y; Zhu Y; Lebel RM; Law M; Nayak KS
Med Phys; 2020 Jan; 47(1):37-51. PubMed ID: 31663134
[TBL] [Abstract][Full Text] [Related]
12. An analysis of the pharmacokinetic parameter ratios in DCE-MRI using the reference region model.
Lee J; Platt S; Kent M; Zhao Q
Magn Reson Imaging; 2012 Jan; 30(1):26-35. PubMed ID: 22071409
[TBL] [Abstract][Full Text] [Related]
13. GOCART: GOlden-angle CArtesian randomized time-resolved 3D MRI.
Zhu Y; Guo Y; Lingala SG; Lebel RM; Law M; Nayak KS
Magn Reson Imaging; 2016 Sep; 34(7):940-50. PubMed ID: 26707849
[TBL] [Abstract][Full Text] [Related]
14. Can dynamic contrast-enhanced MRI evaluate VEGF expression in brain glioma? An MRI-guided stereotactic biopsy study.
Di N; Cheng W; Jiang X; Liu X; Zhou J; Xie Q; Chu Z; Chen H; Wang B
J Neuroradiol; 2019 May; 46(3):186-192. PubMed ID: 29752976
[TBL] [Abstract][Full Text] [Related]
15. Optimization of DCE-MRI protocol for the assessment of patients with brain tumors.
Artzi M; Liberman G; Nadav G; Blumenthal DT; Bokstein F; Aizenstein O; Ben Bashat D
Magn Reson Imaging; 2016 Nov; 34(9):1242-1247. PubMed ID: 27451404
[TBL] [Abstract][Full Text] [Related]
16. Greybox: A hybrid algorithm for direct estimation of tracer kinetic parameters from undersampled DCE-MRI data.
Rastogi A; Yalavarthy PK
Med Phys; 2024 Jan; ():. PubMed ID: 38214325
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic Analysis of Enhancement-Constrained Acceleration (ECA) reconstruction-based high temporal resolution breast DCE-MRI.
Ren Z; Easley TO; Pineda FD; Guo X; Barber RF; Karczmar GS
PLoS One; 2023; 18(6):e0286123. PubMed ID: 37319275
[TBL] [Abstract][Full Text] [Related]
18. Bayesian modeling of Dynamic Contrast Enhanced MRI data in cerebral glioma patients improves the diagnostic quality of hemodynamic parameter maps.
Tietze A; Nielsen A; Klærke Mikkelsen I; Bo Hansen M; Obel A; Østergaard L; Mouridsen K
PLoS One; 2018; 13(9):e0202906. PubMed ID: 30256797
[TBL] [Abstract][Full Text] [Related]
19. Assessment of vessel permeability by combining dynamic contrast-enhanced and arterial spin labeling MRI.
Liu HL; Chang TT; Yan FX; Li CH; Lin YS; Wong AM
NMR Biomed; 2015 Jun; 28(6):642-9. PubMed ID: 25880892
[TBL] [Abstract][Full Text] [Related]
20. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM
Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
